Back to results
US 2003/0120072 A1Published application
Decahydro-isoquinolines
AssigneeNovartis AG
InventorThomas J. Troxler
Life of this patent
Estimating the term…
Abstract
1 The invention provides compounds of formula (I), wherein A, B and R are as defined in the description, and the preparation thereof. The compounds of formula (I) are useful as somatostatin receptor antagonists.
Claims9
A compound of formula I
- 10
- wherein R is hydrogen or (C1-4)alkyl and A and B, independently, are groups of formula (a), (b), (c), (d) or (e)
- 11
- wherein
- X, X1 and X2, independently, are —CR1═ or —N═
- Y is -0-, —S—, —CH═CH— or —NH—
- R1 and R′1, independently, are hydrogen, (C1-4)alkyl or (C1-4)alkoxy,
- R2 is hydrogen, (C1-4)alkyl, (C1-4)alkoxy, (C1-4)alkoxycarbonyl or halogen, and
- R3 and R4, independently, are halogen, nitro, cyano, trifluoromethyl, (C1-4)alkyl, (C1-4) alkoxy, (C1-4)alkoxycarbonyl or (C1-4)alkanoyl,
- in free base or acid addition salt form.
7 more elements
[4-(3,4-Difluoro-phenyl)-piperazin-1-yl]-{(4S ,4aS,8aR)-2-[(S)-3-(6-methoxy-pyridin-3-yl)-2-methyl-propyl]-decahydro-isoquinolin-4yl}-methanone in free base or acid addition salt form.
Dependencies are inferred from the claim text.